Epidemiology and updated management for autoimmune liver disease
Nae-Yun Heo, Haeryoung Kim
Clin Mol Hepatol. 2023;29(1):194-196.   Published online 2022 Dec 14     DOI: https://doi.org/10.3350/cmh.2022.0387
Citations to this article as recorded by Crossref logo
Risk of hepatocellular carcinoma in Asian patients with primary biliary cholangitis: A nationwide and hospital cohort study
Jihye Lim, Ye-Jee Kim, Sehee Kim, Jonggi Choi
JHEP Reports.2025; 7(2): 101251.     CrossRef
Immune traits in combination with inflammatory proteins revealing the pathogenesis of autoimmune liver diseases: A Mendelian randomization study
Feifan Wang, Lu Chen, Yu Tian
Cytokine.2025; 185: 156815.     CrossRef
A Closer Look into Autoimmune Liver Diseases
Branka Filipovic, Marija Marjanovic-Haljilji, Dragana Blagojevic, Milica Dragovic, Emilija Krsmanovic, Ana Matovic, Natasa Panic, Stanimir Kiurski, Zagor Zagorac, Miljan Milanovic, Olivera Markovic, Aleksandra Djokovic, Tijana Glisic, Sanja Dragasevic, Du
International Journal of Molecular Sciences.2025; 26(5): 1863.     CrossRef
Pruritus in Chronic Cholestatic Liver Diseases, Especially in Primary Biliary Cholangitis: A Narrative Review
Tatsuo Kanda, Reina Sasaki-Tanaka, Naruhiro Kimura, Hiroyuki Abe, Tomoaki Yoshida, Kazunao Hayashi, Akira Sakamaki, Takeshi Yokoo, Hiroteru Kamimura, Atsunori Tsuchiya, Kenya Kamimura, Shuji Terai
International Journal of Molecular Sciences.2025; 26(5): 1883.     CrossRef
Evaluation of autoimmune liver disease natural history in patients referred to Middle East Liver Diseases (MELD) center
Seyed Erfan Mehdi Nejad, Mohammad Heiat, Mohammad Javanbakht, Seyed Moayed Alavian, Mohammad Ali Abyazi Haris
BMC Gastroenterology.2024;[Epub]     CrossRef
Artemisia capillaris Thunb. Polysaccharide alleviates cholestatic liver injury through gut microbiota modulation and Nrf2 signaling pathway activation in mice
Jingyi Cai, Zhenyun Zhu, Yuanyuan Li, Qi Li, Tian Tian, Qian Meng, Tianming Wang, Yueming Ma, Jiasheng Wu
Journal of Ethnopharmacology.2024; 327: 118009.     CrossRef
JCAD, a new potential therapeutic target in cholestatic liver disease
Byoung Kuk Jang
Clinical and Molecular Hepatology.2024; 30(2): 166.     CrossRef
Evaluation of the histological scoring systems of autoimmune hepatitis: A significant step towards the optimization of clinical diagnosis
Atsumasa Komori
Clinical and Molecular Hepatology.2024; 30(2): 157.     CrossRef
Magnetic resonance imaging technique to quantify biomarkers for chronic liver diseases
Yu. N. Savchenkov, G. E. Trufanov, V. A. Fokin, A. Yu. Efimtsev, S. E. Arakelov, I. Yu. Titova, A. R. Meltonyan
Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH).2024; 14(1): 159.     CrossRef
Risk of Extrahepatic Malignancies in Patients With Autoimmune Hepatitis: A Nationwide Cohort Study
Sung Won Chung, Ye-Jee Kim, Jihye Lim, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Sehee Kim, Won-Mook Choi
American Journal of Gastroenterology.2024;[Epub]     CrossRef
Comparison of four histological scoring systems for autoimmune hepatitis to improve diagnostic sensitivity
Soomin Ahn, Sook-Hyang Jeong, Eun Ju Cho, Kyoungbun Lee, Gilhyang Kim, Haeryoung Kim
Clinical and Molecular Hepatology.2023; 30(1): 37.     CrossRef